Renalytix Plc

NASDAQ
RNLX
paper.types.company
Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0%
Setor: Healthcare

0.142 $

0 $ 0%
0.1321 $
0.45 $

paper.min_max_per_year

Cronograma de promoção Renalytix Plc

Agenda avançada Gráfico simples
Financial Markets by TradingView
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

Parâmetros básicos

IPO date
2020-07-17
ISIN
US75973T1016
Industry
Health Care Technology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
link
Todos os parâmetros

Nota

Subestimação
Nome Significado Nota
P/S 16.65 1
P/BV -4.85 0
P/E 0 0
Eficiência
Nome Significado Nota
ROA -133.59 0
ROE -631.25 0
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0 0
Crescimento médio dos dividendos 0 0
Obrigação
Nome Significado Nota
Debt/EBITDA -0.2993 10
Debt/Ratio 1.07 8
Debt/Equity -2.02 10
Impulso de crescimento
Nome Significado Nota
Receita, % 52.6 7
Ebitda, % 156.95 10
EPS, % -1.23 0
Mais detalhes

paper.price.prices

Preço Common.min. Common.max. Mudar paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.90d 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %
common.calendar.number_days.180d 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %
common.calendar.number_days.1y 0.3302 $ 0.1321 $ 0.45 $ -57 % 0 % 0 %
common.calendar.number_days.3y 2.53 $ 0.1321 $ 4.01 $ -94.39 % 0 % 0 %
common.calendar.number_days.5y 16.1 $ 0.1321 $ 34.78 $ -99.12 % 0 % 0 %
common.calendar.number_days.10y 0.1321 $ 0.1321 $ 34.78 $ +107.49 % 0 % 0 %
common.calendar.number_days.ytd 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %

Principais proprietários

Empresas semelhantes

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestão da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. James R. McCullough M.B.A. Chief Executive Officer 1.04M 1968 (57 anos)
Mr. Howard B. Doran Jr. President N/A 1961 (64 ano)
Mr. Salim Gulamabbas Hamir F.C.A. Company Secretary N/A
Mr. Joel R. Jung MBA Interim CFO & Principal Accounting Officer 1958 (67 anos)

Informações da empresa

Endereço: United States, New York. NY, 1460 Broadway - Abrir no google maps, Abrir mapas yandex
Site: https://renalytix.com

Sobre a empresa Renalytix Plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.